ABBVON

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Kripto AdıABBVON

SıralamaNo.3143

Piyasa Değeri$0.00

Tamamen Seyreltilmiş Değer$0.00

Pazar Payı%

İşlem Hacmi/Piyasa Değeri (24 Sa)412,835.30%

Dolaşımdaki Arz210.07193405

Maksimum Arz0

Toplam Arz210.07193405

Dolaşım Oranı%

Arz Tarihi--

Varlığın ilk arz edildiği fiyat--

Tüm Zamanların En Yükseği235.09684688380833,2026-02-17

En Düşük Fiyat207.47261007076094,2026-02-04

Herkese Açık Blok ZinciriETH

HakkındaAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Sektör

Sosyal Medya

• Resmi Websitesi
• Blok Gezgini

etfindex:mc_etfindex_sourceYasal Uyarı: Veriler cmc tarafından sağlanmıştır ve yatırım tavsiyesi olarak değerlendirilmemelidir.